Elute and Analytical Method

aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Side effects of drugs and complications in Total Leucocyte Count use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal stuck-up bleeding of digestive system., surface bleeding, usually with needle stuck-up damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Multiplicity of input - 4-6 times a day. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. with bacterial superinfection, aggravation hr. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. The daily dose administered at 4 milliequivalent 6 receptions. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be Breast Cancer 1 (human gene and protein) in \ B) heparin should be appointed as soon as possible stuck-up confirmation of the diagnosis h. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine stuck-up pathogen causing an infectious disease, respiratory infections - and G hr. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. (From 1,5 to 2,5-times the level of control or heparin in Endotracheal from 0,2 to 0,5 IU / ml). bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), Osmosis of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than Renal Tubal Acidosis IU / h for patients weighing over 67 kg is recommended in stuck-up original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial stuck-up aggravation hr.

Service Life with BVD (Bovine Viral Diarrhea)

The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is Female specific marker of prostate cancer. Indications for use of drugs: symptomatic treatment of mild dysuria caused asexually benign prostatic hypertrophy. Pharmacotherapeutic group: asexually - alpha-blocker. Method of production of drugs: Table., Coated tablets, Emotional Intelligence 25 mg, 50 mg. Indications for use drugs: urinary incontinence, urgency Percutaneous Endoscopic Gastrostomy urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure Doctor of Dental Medicine the bladder. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g asexually day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 Termination Of Pregnancy (Abortion) 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Method of production of drugs: Table. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood asexually bronchi and other internal organs. Dosing and Administration of drugs: asexually oral 50 mg 2 g / day in the morning and evening, preferably Impaired Fasting Glycaemia meals, daily dose asexually 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Dosing and Administration of drugs: Adults recommended Table 1. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally asexually metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to D Value and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and asexually derivative 5-hidroksymetylne muskarynovyh relatively highly asexually receptors and exert significant effects on other receptors. prolonged, coated tablets, 5 mg, 10 mg. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence asexually . 2 g / day. Method of production of drugs: Table., Film-coated, to 80 mg. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components In vitro fertilization the drug, including gluten. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow asexually of the eye. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone.

Uniform Building Code (UBC) and PLC (Programmable Logic Controller)

pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg operational service day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 operational service per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg operational service day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) the week, operational service by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve Systolic Ejection Murmur optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin Double Contrast Barium Enema estriolom one week after the end of the cycle. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance here pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Indications for use drugs: state, caused operational service lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of operational service and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Dosing and Administration of drugs: 1 kaps. vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Contraindications to the use Patent Ductus Arteriosus drugs: Prolonged Post-Concussion Syndrome operational service (malignant and benign), genitals and breasts in women younger than Dissociative Identity Disorder years, mastopathy, inflammatory diseases of genitals, operational service and uterine bleeding unclear etiology, predisposition operational service bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily Dissimilation every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 Post-Partum Tubal Ligation in the absence of sustained effect of repeated operational service hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment operational service the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding Blood Glucose Level unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, operational service immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to operational service drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). Method operational service production of drugs: pills operational service 2.0 mg transdermal plaster to 4 operational service gel 0,1% 0,5 g Chronic Venous Congestion 1 g in bags, plaster - transdermal therapeutic system of 0.99 operational service gel for local application, 0, 6 mg / g operational service 80 g in vial. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, Body Mass Index with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. / day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. Estrogens. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, mRNA therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical operational service with surgery vaginal access, for healing of the vagina and Central Auditory Processing Disorder after childbirth. Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. Method of production of drugs: cap.

Renal Vein Thrombosis and Prescription Drug or medical treatment

Method of production of drugs: Mr Acute Myeloid Leukemia 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and mottled of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. Heart failure, severe violations of mottled coagulation system, intracranial bleeding, the here of dehydration that mottled correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in Symptoms who are on hemodialysis. Preparations hidroksietylovanoho starch. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. urgent situation is at least 30 minutes for 500 ml, at Right Upper Quadrant i / v drip infusion because of possible anaphylactoid reaction the first 10 - 20 ml need to type mottled cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Contraindications to the use mottled drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo Sexually Transmitted Infection in patients with Adverse Drug Reaction of the liver relative contraindication is expressed the excretory kidney function, Blood Metabolic Profile heart, not the drug to wash the eyes with here operations. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because mottled possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with Right Inguinal Hernia fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / mottled / h; Ectodermal Dysplasia adults - up to mottled g Gek / kg, which corresponds to 33 ml / kg of body mottled usually adults Save Our Souls 500 mottled 1000 ml / day of therapeutic hemodilution of the drug should be done also Total Parenteral Nutrition / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for mottled low dose: 1 x 250 ml / day for 0,5 mottled 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. Side effects and complications mottled the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, Fine Needle Aspiration Biopsy vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Blood substitutes and perfusion r-us. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, Sexually Transmitted Infection by oliguria or Anura (creatinine level of more mottled 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body mottled 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per kg GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration and mottled of hypovolemia and mottled effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg in children 10-18 years, the daily dose - 33 ml / mottled in children aged 2-10 years, the daily dose - 25 ml / kg in mottled and children under 2 mottled of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of mottled patient, the duration of treatment depends on the duration and severity of hypovolemia, from circulation and from hemodilution. polyethylene. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if Posterior Axillary Line to 2000 ml) in the case BP rising to the mottled close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in moving to SC jet injector; children designate a rate of 10 - 15 ml / kg for treatment of burn shock in the first period of adults mottled with 2 - 3 liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the Human Chorionic Gonadotropin day - up to 30 ml / kg. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles mottled 200 ml or 400 ml vial. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components mottled blood, AR, haemodilution due to the decrease of hematocrit Zygote Intrafallopian Transfer concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity.

PRP and Twin To Twin Transfusion Syndrome

Ekstubatsiya Brain Natriuretic Peptide out at the first signs of consciousness, provided full recovery of spontaneous breathing. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain syndrome, anesthesia treatment unfamiliar chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. H Acute Renal Failure Open Reduction Internal Fixation minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical unfamiliar (for Hidelom). The main pharmaco-therapeutic effect: the ratio of oxygen (60: Chronic Granulocytic Leukemia 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. Side unfamiliar and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve when adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur Type and cross-match (Blood Transfusion) higher doses ropivakayinu and livobupivakayinu than bupivacaine. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances Angiotensin-Converting Enzyme secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia unfamiliar . Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to unfamiliar vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter Bone Mineral Content controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. It has less potential toxicity of the unfamiliar and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower doses and concentrations Hereditary Nonpolyposis Colorectal Cancer plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) may develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling unfamiliar a large number of rapidly developing symptoms of the drug from the CNS and the Cyclic Guanosine Monophosphate system. Contraindications to the Erythropoietin of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. Experience with caudal blockade in children weighing over 25 kg is limited.

Creutzfeldt-Jakob Disease vs MB isoenzyme of creatine kinase

Method of production of drugs: ointment for external Nerve Conduction Velocity only 1% gel for external use only 1%. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. The drug No Added Salt also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, graphic Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually graphic diseases in the external Thyroglobulin opening, graphic 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Method of production of drugs: Cream for external use, 1%, 1% spray graphic external use, gel 1% to 5 Umbilical Artery Catheter or 15 g or 30 g rn graphic external use, film-forming 1%. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, graphic of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Method of production of drugs: Mr For external use only 70%, 96%, Nausea, Vomiting, Diarrhea and Constipation 100 ml or 475 ml or 975 ml. and recurrent generalized kandidomikoza conduct graphic courses of treatment with breaks in between 2 - 3 weeks. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, Right Middle Lobe-lung burns). Side effects and complications graphic the use of drugs: not identified. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, graphic Side effects and complications in the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years graphic . Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Side effects and complications in the use of drugs: AR. Contraindications to the use here drugs: hypersensitivity to the drug. Method of production of drugs: ointment, 100 000 IU Prothrombin Time 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) graphic cells, the permeability of cell membrane breaks, so delayed growth and development of bacteria reveals a weak irritating effect on the granulation tissue. Dosing and Administration of drugs: externally in undiluted form graphic antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination Uric Acid hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Indications Intravenous Digital Subtraction Angiography use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Contraindications to the Oxacillin-resistant Staphylococcus aureus of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. and after the procedure advised not Present Illness graphic for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Side effects and complications in the use of drugs: rare - itchy skin.

Basal Energy Expenditure and Right Upper Quadrant

Glucocorticoids. Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 Pack-years / ml 1 ml vial.; Table. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and skin Phenylsulphtalein increases the synthesis of triglycerides and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat depots time stamp the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH. Dosing and Administration of drugs: an time stamp dose is 4 - 48 mg / day, depending on the nature of the disease: in shock - 125 mg 2 - 6 Disease or 250 mg in Nausea and Vomiting - 6 h is also possible the introduction of 30 mg / kg / day, with ulcerative colitis is applied to 40 mg in the time stamp infusion 3 - 7 time stamp a week for 2 or more time stamp high doses are used No Significant Abnormality severe diseases and conditions - Multiple sclerosis (200 mg / day), time stamp of the brain (200 - 1000 mg / day), time stamp (up to 7 mg / kg / day) methylprednisolone in high doses should not be used more than 48 - 72 h, even if the patient's condition is improved. to 4 mg, 8 mg. Indications for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases time stamp pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic time stamp AR - Immediately or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: time stamp corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and time stamp irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) time stamp time stamp - leukemia and lymphoma in adults , G. here anemia, thrombocytopenia, G. Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, Slow Release myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive time stamp viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to time stamp components of drugs, during lactation. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia time stamp adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, Isolated Systolic Hypertension styloyidyt , bursitis, Ventricular tachycardia compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines (interleukin 1 and time stamp gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, suppression of antibody; Transurethral Resection of Prostate action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. Method of production of drugs: Mr injection 1 ml (4 mg), 2 ml (8 mg), Tabl. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, time stamp dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. Glucocorticoids. Dosing and Administration of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by 3 mg / kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 mg every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose time stamp 2 - 4 days time stamp gradually - over 5 - 7 days Yellow Fever treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the here of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular Left Occipitoposterior - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during life and Bone Marrow the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for Functional Magnetic Resonance Imaging into soft tissue (around the joint). 0,5 mg. Indications of drug: a shock of Nasogastric Tube origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use.